跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XYLOTIN 50 - LIDOCAINE HYDROCHLORIDE INJECTION USP 50MG/5ML - HSA Drug Approval Details
Approvals
/
HSA
/
XYLOTIN 50 - LIDOCAINE HYDROCHLORIDE INJECTION USP 50MG/5ML
Approved
THERAPEUTIC
XYLOTIN 50 - LIDOCAINE HYDROCHLORIDE INJECTION USP 50MG/5ML
ASPIRO PHARMA LIMITED (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Jun 12, 2020
Approval ID
c7666fb43e622a86
Company
ASPIRO PHARMA LIMITED (INDIA)
Type
Therapeutic
Approval Details
Approval Id
c7666fb43e622a86
Drug Name
XYLOTIN 50 - LIDOCAINE HYDROCHLORIDE INJECTION USP 50MG/5ML
Product Name
XYLOTIN 50 - LIDOCAINE HYDROCHLORIDE INJECTION USP 50MG/5ML
Approval Number
SIN15952P
Approval Date
2020-06-12
Registrant
HETERO SINGAPORE PTE. LTD.
Licence Holder
HETERO SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
N01BB02
Atc Item Name
lidocaine
Pharma Manufacturer Name
HETERO SINGAPORE PTE. LTD.
Active Ingredients
Lidocaine Hydrochloride
50mg/5ml
LIDOCAINE HYDROCHLORIDE
50 MG/5 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Jun 12, 2020
Approval ID
c7666fb43e622a86
Type
Therapeutic
Back to HSA Approvals
